{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,4,23]],"date-time":"2026-04-23T12:44:41Z","timestamp":1776948281210,"version":"3.51.4"},"reference-count":15,"publisher":"Elsevier BV","license":[{"start":{"date-parts":[[2016,10,1]],"date-time":"2016-10-01T00:00:00Z","timestamp":1475280000000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2016,10,1]],"date-time":"2016-10-01T00:00:00Z","timestamp":1475280000000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"},{"start":{"date-parts":[[2016,10,1]],"date-time":"2016-10-01T00:00:00Z","timestamp":1475280000000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-017"},{"start":{"date-parts":[[2016,10,1]],"date-time":"2016-10-01T00:00:00Z","timestamp":1475280000000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-037"},{"start":{"date-parts":[[2016,10,1]],"date-time":"2016-10-01T00:00:00Z","timestamp":1475280000000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-012"},{"start":{"date-parts":[[2016,10,1]],"date-time":"2016-10-01T00:00:00Z","timestamp":1475280000000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-029"},{"start":{"date-parts":[[2016,10,1]],"date-time":"2016-10-01T00:00:00Z","timestamp":1475280000000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-004"}],"content-domain":{"domain":["clinicalkey.com","clinicalkey.com.au","clinicalkey.es","clinicalkey.fr","clinicalkey.jp","em-consulte.com","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Biomedicine & Pharmacotherapy"],"published-print":{"date-parts":[[2016,10]]},"DOI":"10.1016\/j.biopha.2016.07.018","type":"journal-article","created":{"date-parts":[[2016,7,26]],"date-time":"2016-07-26T00:34:07Z","timestamp":1469493247000},"page":"635-640","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":37,"special_numbering":"C","title":["Thymoquinone: An edible redox-active quinone for the pharmacotherapy of neurodegenerative conditions and glial brain tumors. A short review"],"prefix":"10.1016","volume":"83","author":[{"given":"Ilhan","family":"Elmaci","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"ORCID":"https:\/\/orcid.org\/0000-0001-7804-4087","authenticated-orcid":false,"given":"Meric A.","family":"Altinoz","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"78","reference":[{"issue":"5","key":"10.1016\/j.biopha.2016.07.018_bib0005","doi-asserted-by":"crossref","first-page":"740","DOI":"10.1016\/j.phymed.2013.10.023","article-title":"Radiation-modifying abilities of Nigella sativa and thymoquinone on radiation-induced nitrosative stress in the brain tissue","volume":"21","author":"Ahlatci","year":"2014","journal-title":"Phytomedicine"},{"issue":"9","key":"10.1016\/j.biopha.2016.07.018_bib0010","doi-asserted-by":"crossref","first-page":"e72882","DOI":"10.1371\/journal.pone.0072882","article-title":"Thymoquinone inhibits autophagy and induces cathepsin-mediated, caspase-independent cell death in glioblastoma cells","volume":"8","author":"Racoma","year":"2013","journal-title":"PLoS One"},{"issue":"6","key":"10.1016\/j.biopha.2016.07.018_bib0015","doi-asserted-by":"crossref","first-page":"2121","DOI":"10.1007\/s10637-011-9777-3","article-title":"Thymoquinone reduces migration and invasion of human glioblastoma cells associated with FAK, MMP-2 and MMP-9 down-regulation","volume":"30","author":"Kolli-Bouhafs","year":"2012","journal-title":"Invest. New Drugs"},{"issue":"3","key":"10.1016\/j.biopha.2016.07.018_bib0020","doi-asserted-by":"crossref","first-page":"127","DOI":"10.1159\/000234466","article-title":"Effects of Nigella sativa oil and thymoquinone on oxidative stress and neuropathy in streptozotocin-induced diabetic rats","volume":"84","author":"Hamdy","year":"2009","journal-title":"Pharmacology"},{"issue":"9","key":"10.1016\/j.biopha.2016.07.018_bib0025","doi-asserted-by":"crossref","first-page":"621","DOI":"10.1016\/j.phymed.2006.12.005","article-title":"Effect of thymoquinone and Nigella sativa seeds oil on lipid peroxidation level during global cerebral ischemia-reperfusion injury in rat hippocampus","volume":"14","author":"Hosseinzadeh","year":"2007","journal-title":"Phytomedicine"},{"issue":"1","key":"10.1016\/j.biopha.2016.07.018_bib0030","doi-asserted-by":"crossref","first-page":"39","DOI":"10.1007\/s10735-010-9305-3","article-title":"Protective effects of thymoquinone on the neuronal injury in frontal cortex after chronic toluene exposure","volume":"42","author":"Kanter","year":"2011","journal-title":"J. Mol. Histol."},{"issue":"1\u20133","key":"10.1016\/j.biopha.2016.07.018_bib0035","doi-asserted-by":"crossref","first-page":"40","DOI":"10.1016\/j.ejphar.2006.05.046","article-title":"Neuroprotective effects of thymoquinone against transient forebrain ischemia in the rat hippocampus","volume":"543","author":"Al-Majed","year":"2006","journal-title":"Eur. J. Pharmacol."},{"issue":"3","key":"10.1016\/j.biopha.2016.07.018_bib0040","doi-asserted-by":"crossref","DOI":"10.1007\/s12031-013-0043-3","article-title":"Thymoquinone attenuates astrogliosis, neurodegeneration, mossy fiber sprouting, and oxidative stress in a model of temporal lobe epilepsy","volume":"51","author":"Dariani","year":"2013","journal-title":"J. Mol. Neurosci."},{"issue":"1","key":"10.1016\/j.biopha.2016.07.018_bib0045","doi-asserted-by":"crossref","first-page":"35","DOI":"10.1007\/s12017-014-8337-3","article-title":"Thymoquinone and vitamin C attenuates pentylenetetrazole-induced seizures via activation of GABAB1 receptor in adult rats cortex and hippocampus","volume":"17","author":"Ullah","year":"2015","journal-title":"Neuromol. Med."},{"issue":"1\u20133","key":"10.1016\/j.biopha.2016.07.018_bib0050","doi-asserted-by":"crossref","first-page":"62","DOI":"10.1016\/j.ejphar.2013.01.036","article-title":"Inhibition of brain oxidative stress and inducible nitric oxide synthase expression by thymoquinone attenuates the development of morphine tolerance and dependence in mice","volume":"702","author":"Abdel-Zaher","year":"2013","journal-title":"Eur. J. Pharmacol."},{"issue":"3","key":"10.1016\/j.biopha.2016.07.018_bib0055","doi-asserted-by":"crossref","first-page":"660","DOI":"10.1016\/S1734-1140(11)70577-1","article-title":"Thymoquinone produced antianxiety-like effects in mice through modulation of GABA and NO levels","volume":"63","author":"Gilhotra","year":"2011","journal-title":"Pharmacol. Rep."},{"issue":"1","key":"10.1016\/j.biopha.2016.07.018_bib0060","doi-asserted-by":"crossref","first-page":"13","DOI":"10.1016\/j.etp.2013.07.002","article-title":"Thymoquinone ameliorates lead-induced brain damage in Sprague Dawley rats","volume":"66","author":"Radad","year":"2014","journal-title":"Exp. Toxicol. Pathol."},{"issue":"9","key":"10.1016\/j.biopha.2016.07.018_bib0065","doi-asserted-by":"crossref","first-page":"2128","DOI":"10.1111\/j.1742-4658.2010.07629.x","article-title":"Effects of thymoquinone on isolated and cellular proteasomes","volume":"277","author":"Cecarini","year":"2010","journal-title":"FEBS J."},{"issue":"8","key":"10.1016\/j.biopha.2016.07.018_bib0070","doi-asserted-by":"crossref","first-page":"e12124","DOI":"10.1371\/journal.pone.0012124","article-title":"Thymoquinone induces telomere shortening, DNA damage and apoptosis in human glioblastoma cells","volume":"5","author":"Gurung","year":"2010","journal-title":"PLoS One"},{"issue":"5","key":"10.1016\/j.biopha.2016.07.018_bib0075","doi-asserted-by":"crossref","first-page":"1813","DOI":"10.1007\/s10637-011-9734-1","article-title":"Anti-neoplastic agent thymoquinone induces degradation of \u03b1 and \u03b2 tubulin proteins in human cancer cells without affecting their level in normal human fibroblasts","volume":"30","author":"Alhosin","year":"2012","journal-title":"Invest. New Drugs"}],"container-title":["Biomedicine & Pharmacotherapy"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0753332216307302?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0753332216307302?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2026,4,23]],"date-time":"2026-04-23T11:48:16Z","timestamp":1776944896000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S0753332216307302"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2016,10]]},"references-count":15,"alternative-id":["S0753332216307302"],"URL":"https:\/\/doi.org\/10.1016\/j.biopha.2016.07.018","relation":{},"ISSN":["0753-3322"],"issn-type":[{"value":"0753-3322","type":"print"}],"subject":[],"published":{"date-parts":[[2016,10]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Thymoquinone: An edible redox-active quinone for the pharmacotherapy of neurodegenerative conditions and glial brain tumors. A short review","name":"articletitle","label":"Article Title"},{"value":"Biomedicine & Pharmacotherapy","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.biopha.2016.07.018","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2016 Elsevier Masson SAS. All rights reserved.","name":"copyright","label":"Copyright"}]}}